Impact of Bifidobacterium animalis subsp. lactis BLa80 and Lacticaseibacillus rhamnosus LRa05 supplementation on the gut microbiota and metabolic health of alcohol-consuming individuals: a randomised, double-blind, placebo-controlled trial
supplementation with BLC appears to beneficially modulate the composition of the gut microbiota, aiding in the management of alcohol-related gastrointestinal disturbances and dependency. These findings highlight BLC's potential as a therapeutic adjunct for alcohol-induced gut dysbiosis, offering a non-pharmacological strategy to mitigate metabolic risks and improve gut barrier integrity in individuals with chronic alcohol consumption. This intervention may significantly contribute to gut health improvement.
Authors
- Fei Xu (ORCID: https://orcid.org/0000-0001-6139-2552)
- Chunhua Zhu (ORCID: https://orcid.org/0000-0001-6136-2150)
- Ying Liu (ORCID: https://orcid.org/0000-0003-0802-3832)
- Yung‐Ming Chen (ORCID: https://orcid.org/0000-0002-9241-1258)
- Yuan Gao (ORCID: https://orcid.org/0000-0003-2596-4773)
- Z. Wang
- Jiayi Wang (ORCID: https://orcid.org/0009-0000-2005-0986)
Institutions
- Henan University of Technology (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
Publication Details
- Journal
- Beneficial Microbes
- Published
- 2025-06-16
- DOI
- https://doi.org/10.1163/18762891-bja00083
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Henan Province